logo

For the Inventor, By the Inventor

Flower Mound, TX, United States of America

Russell McMahen

This inventor holds 12 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Neos Therapeutics, LP, Neos Terapeutics, LP. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell McMahen. Retrieved from https://idiyas.com/inventor/russell-mcmahen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 188(Granted Patents)


Company Filing History:

goldMedal11 out of 13 
 
Neos Therapeutics, LP
 patents
silverMedal1 out of 1 
 
Neos Terapeutics, LP
 patent

Years Active: 2012-2017

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 9839619 - Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles (2017-12-12),
2. 9522120 - Compositions and methods of making sustained release liquid formulations (2016-12-20),
3. 9265737 - Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles (2016-02-23),
4. 9089496 - Compositions comprising methylphenidate complexed with ion-exchange resin particles (2015-07-28),
5. 9072680 - Compositions comprising methylphenidate complexed with ion-exchange resin particles (2015-07-07),
6. 9057675 - Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles (2015-06-16),
7. 9017731 - Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles (2015-04-28),
8. 8840924 - Compositions and methods of making rapidly dissolving ionically masked formulations (2014-09-23),
9. 8709491 - Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles (2014-04-29),
10. 8512759 - Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles (2013-08-20),
11. 8470375 - Method of formulating and designing liquid drug suspensions containing ion exchange resin particles (2013-06-25),
12. 8313770 - Modifying drug release in suspensions of ionic resin systems (2012-11-20),

Title: The Innovative Contributions of Russell McMahen

Introduction

Russell McMahen is a notable inventor based in Flower Mound, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms for treating conditions such as ADD and ADHD. With a total of 12 patents to his name, McMahen's work reflects a commitment to advancing medical treatments.

Latest Patents

Among his latest patents is a method for treating ADD or ADHD that involves administering amphetamine complexed with ion-exchange resin particles. This invention focuses on dosage forms that provide prolonged therapy, enhancing the effectiveness of treatment. Additionally, he has developed compositions and methods for making sustained release liquid formulations. This invention includes controlled release microbeads that allow for the gradual release of active agents in a shelf-stable liquid formulation.

Career Highlights

Throughout his career, McMahen has worked with prominent companies in the pharmaceutical industry, including Neos Therapeutics, LP. His innovative approaches have contributed to the development of new therapeutic options for patients.

Collaborations

McMahen has collaborated with various professionals in his field, including Mark Tengler and Daniel Lockhart. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Russell McMahen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of ADD and ADHD, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…